# Trametinib in the Treatment of Complicated Extracranial Arterial Venous Malformation

> **NCT04258046** · PHASE2 · COMPLETED · sponsor: **Stanford University** · enrollment: 25 (actual)

## Conditions studied

- Venous Malformation
- Arterial Disease

## Interventions

- **DRUG:** Trametinib tablet

## Key facts

- **NCT ID:** NCT04258046
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-01
- **Primary completion:** 2026-02-02
- **Final completion:** 2026-02-18
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2026-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04258046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04258046, "Trametinib in the Treatment of Complicated Extracranial Arterial Venous Malformation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04258046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*